zintick

Annovis Bio ANVS

Annovis Bio, Inc. · NYSE · Pharmaceutical Preparations

$1.13+10.78%close on Oct. 30, 2026 · volume 1.5M · Yahoo Finance

Price, last 49 sessions

$1.00$1.25$1.50$1.75Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 30, 2026 · high $1.82 · low $0.96 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 7 →
  • 8-KOct. 30, 2026, 5:10 p.m. ETView on SEC.govOur explainer

    Delisting notice / failure to meet listing standard · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedAnnovis Bio Receives NYSE Notice for Failure to Meet Continued Listing Standard, Market Cap Near $48.4 Million and Stockholders' Deficit of $(4.3) Million

  • 8-KOct. 19, 2026, 7:49 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedAnnovis Bio, Inc. Corrects Proxy Audit Fee Disclosure: 2025 Total Fees $515,000 vs. $482,045 in 2024

  • SCHEDULE 13G/AOct. 15, 2026, 12:34 p.m. ETView on SEC.gov
  • 10-QAug. 14, 2026, 4:31 p.m. ETView on SEC.gov
  • 8-KAug. 14, 2026, 4:05 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • SCHEDULE 13GAug. 14, 2026, 12:39 p.m. ETView on SEC.gov
  • SCHEDULE 13GJuly 29, 2026, 4:17 p.m. ETView on SEC.gov